Market Insights Health Hospitals Inpatient Care

Neoplasm Treatment - Sweden

Sweden

The Neoplasm Treatment market in Sweden is expected to witness a significant increase in revenue, reaching an estimated amount of US$1.30bn by the year 2024.
This projection indicates a promising growth potential within the industry.
Furthermore, it is anticipated that the market will continue to expand steadily with a compound annual growth rate (CAGR) of 4.37% from 2024 to 2029.
As a result, the market volume is expected to reach US$1.61bn by 2029.
When comparing the global market, it is worth noting that United States is projected to generate the highest revenue in the Neoplasm Treatment market sector, with an estimated amount of US$90.56bn in 2024.
This demonstrates the dominant position of the United States within the industry, both in terms of revenue and market share.
Sweden's neoplasm treatment market has seen a surge in innovative immunotherapy approaches, bolstered by the country's strong research infrastructure and commitment to healthcare innovation.

Key regions: Europe, Canada, Brazil, United States, United Kingdom

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.